Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:countryOfOrigin |
gptkb:United_Kingdom
|
| gptkbp:dissolved |
1999
|
| gptkbp:fate |
merged to form AstraZeneca
|
| gptkbp:foundedIn |
1993
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zeneca
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:keyPerson |
Sir David Barnes
|
| gptkbp:mergedInto |
gptkb:Astra_AB
|
| gptkbp:notableProduct |
gptkb:Zoladex
gptkb:Nolvadex Casodex |
| gptkbp:predecessor |
gptkb:Imperial_Chemical_Industries_(ICI)
|
| gptkbp:successor |
gptkb:AstraZeneca
|
| gptkbp:bfsParent |
gptkb:PleasrDAO
|
| gptkbp:bfsLayer |
5
|